Rapporto annuale 2007 - Istituto di Ricerche Farmacologiche Mario ...
Rapporto annuale 2007 - Istituto di Ricerche Farmacologiche Mario ... Rapporto annuale 2007 - Istituto di Ricerche Farmacologiche Mario ...
IRFMN - Brigham & Women's Hospital, Boston, USA - Hennepin County Medical Center, Minneapolis, USA - SIU School of Medicine, Springfield, USA - The Toronto Hospital, Toronto, Canada - INCUCAI, Buenos Aires, Argentina - Hospital Italiano de Buenos Aires, Buenos Aires, Argentina - Hospital Regional de Valdivia, Valdivia, Cile - Soroka Medical Center, Beer Sheva, Israele PRESENZA IN COMITATI EDITORIALI Journal of the American Society of Nephrology (Piero Ruggenenti) Journal of Nephrology (Piero Ruggenenti) Current Diabetes Reviews (Piero Ruggenenti) Clinical Journal of the American Society of Nephrology (Piero Ruggenenti) Current Pharmacology Reviews (Dario Cattaneo) ATTIVITA' DI REVISIONE American Journal of Physiology-Renal Physiology American Journal of Kidney Diseases American Journal of Transplantation British Journal of Haematology Journal of the American Society of Nephrology (JASN) Clinica Chmica ACTA Clinical Biochemistry Clinical Chemistry Clinical Journal of the American Society of Nephrology (CJASN) Clinical Pharmacology & Therapeutics Current Clinical Pharmacology Current Diabetes Reviews Diabetes Diabetic Medicine Drugs Expert Opinion on Pharmacotherapy Future Medicine Hypertension Journal of Clinical Investigation Journal of Chromatographic Sciences Journal of Clinical Pharmacology Journal of Immunology Journal of Nephrology 297 RAPPORTO ATTIVITA’ 2007
IRFMN Journal of PostGraduate Medicine Kidney International Nature Medicine Lancet Lupus New England Journal of Medicine Nephrology Dialysis and Transplantation Pediatric Nephrology Pediatric Transplantation Plos Talanta Therapy Transplant Immunology Transplantation WHO Bullettin PARTECIPAZIONE AD EVENTI CON CONTRIBUTI DEL DIPARTIMENTO C-440T/T-331C polymorphisms in the UGT-1A9 gene affect the pharmacokinetics of mycophenolic acid in renal transplant recipients”. All’interno dell’ American Transplant Congress, San Francisco, 5-9 Maggio, 2007. “Pharmacokinetics of mycophenolic acid after the conversion from mycophenolate sodium to the mofetil formulation in kidney transplant recipients”. All’interno dell’ IATDMCT Meeting, Nizza, Settembre 2007. “Blood cell count and lipid lowering therapy affect sirolimus exposure in kidney transplant recipients on calcineurin inhibitor-free regimen”. All’interno dell’IATDMCT Meeting, Nizza, Settembre 2007. “Farmacocinetica degli immunosoppressori: update su acido micofenolico”. All’interno del corso di aggiornamento Roche, Isola di Capo Rizzuto, 19 Settembre 2007. “Statine, dislipidemia e nuovi ipolipemizzanti”. All’interno del convegno: Nefropatie croniche e complicanze cardiovascolari. Ranica 1 Dicembre 2007. Conference “Clinical management of hyperglicemia and metabolic syndrome”, Treviglio, Italia, 17 Novembre 2007 Tenth International Conference on Endothelin, Bergamo, Italia, 16-19 Settembre 2007 International Workshop ”Endocannabinoids in Endocrinology, Metabolism and Cardiovascular Disease”, Padua, Italy, 5-7 Luglio, 2007 Retraining course of BLS-D “BASIC LIFE SUPPORT - EARLY DEFIBRILATION”. 28 Marzo 2007 Investigator meeting – Clinical trial PLANET, Barcelona, 9-12 Marzo, 2007 Society for Clinical rials, Montreal Canada, 20-23 Maggio 2007 “Progression of chronic renal disease – The state of the art and an update” 298 RAPPORTO ATTIVITA’ 2007
- Page 247 and 248: IRFMN 246 RAPPORTO ATTIVITA’ 2007
- Page 249 and 250: IRFMN CURRICULA Ariela Benigni si
- Page 251 and 252: IRFMN syndrome. J Clin Invest 2003;
- Page 253 and 254: IRFMN Noris on behalf of the Italia
- Page 255 and 256: IRFMN INTRODUZIONE ALLE ATTIVITA' D
- Page 257 and 258: IRFMN COLLABORAZIONI NAZIONALI Dipa
- Page 259 and 260: IRFMN PARTECIPAZIONE AD EVENTI CON
- Page 261 and 262: IRFMN in systemic lupus. Arthritis
- Page 263 and 264: IRFMN l’apoptosi delle cellule re
- Page 265 and 266: IRFMN L’associazione di inibitori
- Page 267 and 268: IRFMN Caratterizzazione funzionale
- Page 269 and 270: IRFMN 268 RAPPORTO ATTIVITA’ 2007
- Page 271 and 272: IRFMN CURRICULA Andrea Remuzzi si
- Page 273 and 274: IRFMN l'attività di ricerca presso
- Page 275 and 276: IRFMN International Journal of Arti
- Page 277 and 278: IRFMN Remuzzi G, Cravedi P, Costant
- Page 279 and 280: IRFMN studi clinici devono essere c
- Page 281 and 282: IRFMN Sviluppo di un dispositivo pe
- Page 283 and 284: IRFMN 282 RAPPORTO ATTIVITA’ 2007
- Page 285 and 286: IRFMN 284 RAPPORTO ATTIVITA’ 2007
- Page 287 and 288: IRFMN 286 RAPPORTO ATTIVITA’ 2007
- Page 289 and 290: IRFMN CURRICULA Piero Ruggenenti si
- Page 291 and 292: IRFMN Pubblicazioni principali •
- Page 293 and 294: IRFMN INTRODUZIONE ALLE ATTIVITA' D
- Page 295 and 296: IRFMN - Istituto clinico Humanitas,
- Page 297: IRFMN Umbria - Azienda Ospedaliera
- Page 301 and 302: IRFMN SELEZIONE PUBBLICAZIONI SCIEN
- Page 303 and 304: IRFMN Programma di Remissione Clini
- Page 305 and 306: IRFMN consecutive. Nel 2007 è stat
- Page 307 and 308: IRFMN quelli ottenuti con HemoCue 2
- Page 309 and 310: IRFMN Laboratorio di Fasi Avanzate
- Page 311 and 312: IRFMN livello di immunosoppressione
- Page 313 and 314: IRFMN CURRICULA Guido Bertolini si
- Page 315 and 316: IRFMN COLLABORAZIONI NAZIONALI Dipa
- Page 317 and 318: IRFMN Regione Lombardia Regione Tos
- Page 319 and 320: IRFMN fine di estendere il controll
- Page 321 and 322: IRFMN CURRICULA Arrigo Schieppati s
- Page 323 and 324: IRFMN SCOPERTE/RISULTATI PRINCIPALI
- Page 325 and 326: IRFMN Roma, 24 marzo 2007 Malattie
- Page 327 and 328: IRFMN L’attenzione è focalizzata
- Page 329 and 330: IRFMN metà dei pazienti. Non esist
- Page 331 and 332: IRFMN 330 RAPPORTO ATTIVITA’ 2007
- Page 333 and 334: IRFMN CURRICULUM Livio Garattini :
- Page 335 and 336: IRFMN PRESENZA IN COMITATI EDITORIA
- Page 337 and 338: IRFMN Abbott EG Grunenthal-Prodotti
- Page 339 and 340: IRFMN 338 RAPPORTO ATTIVITA’ 2007
- Page 341 and 342: IRFMN 340 RAPPORTO ATTIVITA’ 2007
- Page 343 and 344: IRFMN Una volta ottenuto il Diploma
- Page 345 and 346: IRFMN 344 RAPPORTO ATTIVITA’ 2007
- Page 347 and 348: IRFMN 346 RAPPORTO ATTIVITA’ 2007
IRFMN<br />
Journal of PostGraduate Me<strong>di</strong>cine<br />
Kidney International<br />
Nature Me<strong>di</strong>cine<br />
Lancet<br />
Lupus<br />
New England Journal of Me<strong>di</strong>cine<br />
Nephrology Dialysis and Transplantation<br />
Pe<strong>di</strong>atric Nephrology<br />
Pe<strong>di</strong>atric Transplantation<br />
Plos<br />
Talanta<br />
Therapy<br />
Transplant Immunology<br />
Transplantation<br />
WHO Bullettin<br />
PARTECIPAZIONE AD EVENTI CON CONTRIBUTI DEL<br />
DIPARTIMENTO<br />
C-440T/T-331C polymorphisms in the UGT-1A9 gene affect the pharmacokinetics of<br />
mycophenolic acid in renal transplant recipients”. All’interno dell’ American Transplant<br />
Congress, San Francisco, 5-9 Maggio, <strong>2007</strong>.<br />
“Pharmacokinetics of mycophenolic acid after the conversion from mycophenolate so<strong>di</strong>um to<br />
the mofetil formulation in kidney transplant recipients”. All’interno dell’ IATDMCT Meeting,<br />
Nizza, Settembre <strong>2007</strong>.<br />
“Blood cell count and lipid lowering therapy affect sirolimus exposure in kidney transplant<br />
recipients on calcineurin inhibitor-free regimen”. All’interno dell’IATDMCT Meeting, Nizza,<br />
Settembre <strong>2007</strong>.<br />
“Farmacocinetica degli immunosoppressori: update su acido micofenolico”. All’interno del<br />
corso <strong>di</strong> aggiornamento Roche, Isola <strong>di</strong> Capo Rizzuto, 19 Settembre <strong>2007</strong>.<br />
“Statine, <strong>di</strong>slipidemia e nuovi ipolipemizzanti”. All’interno del convegno: Nefropatie croniche e<br />
complicanze car<strong>di</strong>ovascolari. Ranica 1 Dicembre <strong>2007</strong>.<br />
Conference “Clinical management of hyperglicemia and metabolic syndrome”, Treviglio, Italia,<br />
17 Novembre <strong>2007</strong><br />
Tenth International Conference on Endothelin, Bergamo, Italia, 16-19 Settembre <strong>2007</strong><br />
International Workshop ”Endocannabinoids in Endocrinology, Metabolism and Car<strong>di</strong>ovascular<br />
Disease”, Padua, Italy, 5-7 Luglio, <strong>2007</strong><br />
Retraining course of BLS-D “BASIC LIFE SUPPORT - EARLY DEFIBRILATION”. 28 Marzo <strong>2007</strong><br />
Investigator meeting – Clinical trial PLANET, Barcelona, 9-12 Marzo, <strong>2007</strong><br />
Society for Clinical rials, Montreal Canada, 20-23 Maggio <strong>2007</strong><br />
“Progression of chronic renal <strong>di</strong>sease – The state of the art and an update”<br />
298<br />
RAPPORTO ATTIVITA’ <strong>2007</strong>